Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INTEGRILIN
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
- The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
- A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
- Eptifibatide and ST Segment Resolution Following Primary PCI
- A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
- INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
- Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
Clinical trials list
click for details